Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The current ratio is N/A as of Tuesday, October 6, 2026.
CURRENT RATIO
N/A
Market Cap
$192.58M
Current Ratio
7.90
TTM Avg
9.91
3Y Avg
10.86
5Y Avg
18.34
Market Cap
$191.07M
Current Ratio
14.32
TTM Avg
7.65
3Y Avg
9.22
5Y Avg
9.58
Market Cap
$216.62M
Current Ratio
5.36
TTM Avg
6.17
3Y Avg
11.50
5Y Avg
11.99
Market Cap
$181.64M
Current Ratio
1.59
TTM Avg
1.58
3Y Avg
1.42
5Y Avg
1.43
Market Cap
$178.23M
Current Ratio
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $202.05M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $208.17M | 5.26 | 3.62 | 4.54 | 4.95 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.58M | 7.90 | 9.91 | 10.86 | 18.34 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $191.07M | 14.32 | 7.65 | 9.22 | 9.58 |
| Compugen Ltd. (CGEN)vs › | $215.50M | 5.72 | 5.91 | 5.85 | 7.15 |
| Niagen Bioscience Inc (NAGE)vs › | $214.64M | 6.50 | 4.21 | 3.36 | 3.03 |
| Lyell Immunopharma, Inc. (LYEL)vs › | $216.62M | 5.36 | 6.17 | 11.50 | 11.99 |
| Journey Medical Corporation (DERM)vs › | $181.64M | 1.59 | 1.58 | 1.42 | 1.43 |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.23M | 15.70 | 3.42 | 4.67 | 3.16 |
| Keros Therapeutics, Inc. (KROS)vs › | $225.44M | 21.96 | 18.45 | 17.11 | 21.15 |
Current Ratio
N/A
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
